These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12788234)

  • 1. Asymptotics and bioavailability in multicompartment pharmacokinetic models with enterohepatic circulation.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2003 Jul; 184(1):69-99. PubMed ID: 12788234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.
    Schumann W; Hillesheim HG; Gira G
    Exp Clin Endocrinol; 1986 Jul; 87(2):118-24. PubMed ID: 3758191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
    Hofmann AF; Molino G; Milanese M; Belforte G
    J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterohepatic circulation model for population pharmacokinetic analysis.
    Funaki T
    J Pharm Pharmacol; 1999 Oct; 51(10):1143-8. PubMed ID: 10579685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic model for the enterohepatic circulation of mycophenolic acid].
    Jiao Z; Shen J; Zhong LJ; Yu YQ; Zhong MK
    Yao Xue Xue Bao; 2006 Mar; 41(3):272-6. PubMed ID: 16759002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.
    Roberts MS; Magnusson BM; Burczynski FJ; Weiss M
    Clin Pharmacokinet; 2002; 41(10):751-90. PubMed ID: 12162761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of route-dependent phase-II gut metabolism and enterohepatic circulation on the bioavailability and systemic disposition of resveratrol in rats and humans: A comprehensive whole body physiologically-based pharmacokinetic modeling.
    Han DG; Seo SW; Choi E; Kim MS; Yoo JW; Jung Y; Yoon IS
    Biomed Pharmacother; 2022 Jul; 151():113141. PubMed ID: 35609369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibe.
    Soulele K; Karalis V
    Xenobiotica; 2019 Apr; 49(4):446-456. PubMed ID: 29629619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.
    Kim TH; Shin S; Landersdorfer CB; Chi YH; Paik SH; Myung J; Yadav R; Horkovics-Kovats S; Bulitta JB; Shin BS
    AAPS J; 2015 Sep; 17(5):1210-23. PubMed ID: 25990964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats.
    Watari N; Hanawa M; Iwai M; Kaneniwa N
    J Pharmacobiodyn; 1984 Nov; 7(11):811-9. PubMed ID: 6530646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.
    Okour M; Jacobson PA; Ahmed MA; Israni AK; Brundage RC
    J Clin Pharmacol; 2018 May; 58(5):628-639. PubMed ID: 29329489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.